Effect of psoriasis activity and topical treatment on plasma epidermal growth factor (EGF) and its soluble receptor (sEGFR)

The Immunopathogenesis of Psoriasis

(2015) Jaehwan Kim et al.   DERMATOLOGIC CLINICS

Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales

(2014) I. Flisiak et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis

(2013) Nan-Lin Wu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Indirubin, an acting component of indigo naturalis, inhibits EGFR activation and EGF-induced CDC25B gene expression in epidermal keratinocytes

(2012) Wan-Ling Hsieh et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Elevation of serum epidermal growth factor and interleukin 1 receptor antagonist in active psoriasis vulgaris

(2010) K.S. Anderson et al.   BRITISH JOURNAL OF DERMATOLOGY

EGFR Regulates the Expression of Keratinocyte-Derived Granulocyte/Macrophage Colony-Stimulating Factor In Vitro and In Vivo

(2009) Francesca Mascia et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Beyond Wavy Hairs

(2008) Marlon R. Schneider et al.   AMERICAN JOURNAL OF PATHOLOGY

The epidermal growth factor receptor family: Biology driving targeted therapeutics

(2008) M. J. Wieduwilt et al.   CELLULAR AND MOLECULAR LIFE SCIENCES